Global Beta-2 Microglobulin Testing Market - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities - ResearchAndMarkets.com

The "Global Beta-2 Microglobulin Testing Market: US, Europe, Japan-Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities" report has been added to ResearchAndMarkets.com's offering.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Monday, February 17, 2020
Information
Tags: 
Health, Oncology, Medical devices, Proteins, Market segmentation, Beta-2 microglobulin, Market share, Microglobulin
⚠generated by AI ↴
Summary
Key Points: 
  • The "Global Beta-2 Microglobulin Testing Market: US, Europe, Japan-Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities" report has been added to ResearchAndMarkets.com's offering.
  • During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field.
  • Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumours, and monitoring biological response to cancer therapy.
  • This report presents a detailed analysis of the -2 Microglobulin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.


The "Global Beta-2 Microglobulin Testing Market: US, Europe, Japan-Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities" report has been added to ResearchAndMarkets.com's offering.

The cancer diagnostics market is on the verge of explosion, as researchers approach major technological breakthroughs in tumour diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field.

Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumours, and monitoring biological response to cancer therapy. The rise in the geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

This report presents a detailed analysis of the -2 Microglobulin testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Companies Mentioned

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Grifols
  • GSK Biologicals
  • Hologic
  • Leica Biosystems

For more information about this report visit https://www.researchandmarkets.com/r/ncyvu9

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Copyright: 
Copyright Business Wire 2020